e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Lung cell injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury
B. Bondue, O. Vosters, P. De Nadai, S. Glineur, O. De Henau, S. Luangsay, F. Van Gool, D. Desmecht, P. De Vuyst, M. Parmentier (Brussels, Gosselies, Liège, Belgium)
Source:
Annual Congress 2011 - Lung cell injury and repair
Session:
Lung cell injury and repair
Session type:
Poster Discussion
Number:
4594
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Bondue, O. Vosters, P. De Nadai, S. Glineur, O. De Henau, S. Luangsay, F. Van Gool, D. Desmecht, P. De Vuyst, M. Parmentier (Brussels, Gosselies, Liège, Belgium). Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury. Eur Respir J 2011; 38: Suppl. 55, 4594
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
YS1: Immunomodulatory function of chemerin and its receptor ChemR23 in the physiopathology of viral pneumonia and acute lung injury
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Eur Respir Rev 2006; 15: 207-208
Year: 2006
The role of leptin in pulmonary neutrophilia during murine acute lung injury
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations?
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute
C. pneumoniae
infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006
Role of syndecan-4 in acute lung inflammation
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
The role of TREM-1 and TREM-2 receptors in immunopathogenesis of pulmonary sarcoidosis and hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
The role of pre-receptor glucocorticoid metabolism in regulating the severity and persistence of murine lung injury
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
Source: Eur Respir J 2006 Oct 01;28(4):695-702
Year: 2006
Characterisation of endogenous IL-33 using a model of
Alternaria
-induced pulmonary inflammation
Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways
Year: 2012
Synthetic cannabinoids induce acute lung inflammation
via
cannabinoid receptor 1 activation
Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020
Year: 2020
The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Glucocorticoid receptor expression in different rat models of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Chemokine receptor expression and function of infiltrated neutrophils in inflammatory lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 856s
Year: 2006
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Role of angiopoietins Ang-1 and Ang-2 for the development of acute lung injury in pneumococcal pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment
Source: Eur Respir J 2012; 40: 416-423
Year: 2012
Ghrelin attenuates lipopolysaccharide-induced acute lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 731s
Year: 2005
Lung expression of a novel mediator of bacterial inflammation: TREM-1
Source: Eur Respir J 2001; 18: Suppl. 33, 80s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept